Site-specific modification of hemoglobin by methyl acetyl phosphate

Area of Science:

• Biochemistry
• Protein Chemistry
• Molecular Biology

Background:

• Methyl acetyl phosphate was initially developed as a site-specific reagent for hydroxybutyrate dehydrogenase.
• Hemoglobin's 2,3-diphosphoglycerate binding site is crucial for regulating oxygen affinity.
• Understanding hemoglobin modification is key to studying its function and related diseases.

Purpose of the Study:

• To investigate the reactivity and specificity of methyl acetyl phosphate with human hemoglobin.
• To identify the specific sites of hemoglobin acetylation by methyl acetyl phosphate.
• To determine if methyl acetyl phosphate exhibits selectivity towards alpha or beta chains.

Main Methods:

• Incubation of human hemoglobin with methyl acetyl phosphate.
• Peptide mapping and amino acid analysis to identify modified residues.
• Comparison of acetylation patterns between alpha and beta chains.

Main Results:

• Methyl acetyl phosphate acetylates three specific residues in the hemoglobin beta-chain cleft: Val-1, Lys-82, and Lys-144.
• No detectable acetylation occurred on the alpha-chain amino groups.
• The observed acetylation pattern suggests a specific interaction with the 2,3-diphosphoglycerate binding site.

Conclusions:

• Methyl acetyl phosphate demonstrates high specificity for the hemoglobin beta-chain cleft.
• The reagent selectively targets residues near the 2,3-diphosphoglycerate binding site.
• These findings highlight the utility of methyl acetyl phosphate for studying hemoglobin structure and function.